ICL Group (NYSE: ICL) has received a downgrade from Wall Street Zen, moving from a “buy” rating to a “hold” rating, as detailed in a report released on Sunday. This shift in rating comes shortly after the company reported its quarterly earnings, revealing mixed results that have prompted scrutiny from various analysts.
In addition to Wall Street Zen’s assessment, other financial institutions have also expressed cautious positions regarding ICL Group. Weiss Ratings reaffirmed a “hold (c)” rating on the company’s shares on December 29, 2023. Meanwhile, Barclays reduced its price target for ICL Group from $7.00 to $6.00 and assigned an “equal weight” rating in a report published on November 13, 2023. Currently, the consensus rating for ICL Group, based on data from MarketBeat.com, stands at “hold,” with an average target price of $6.23.
Quarterly Earnings and Performance Overview
ICL Group’s latest quarterly earnings report, released on February 18, 2024, revealed earnings per share of $0.09, aligning with analysts’ expectations. Despite meeting earnings projections, the company reported a net margin of 3.16% and a return on equity of 7.44%, indicating some challenges in profitability. Revenue for the quarter was $1.70 billion, falling short of the anticipated $1.77 billion. Analysts forecast that ICL Group is projected to achieve an earnings per share of $0.37 for the current fiscal year.
Institutional Investors Adjust Holdings
Recent transactions by institutional investors reflect a significant interest in ICL Group. Caprock Group LLC acquired a new stake valued at approximately $1,180,000 during the third quarter. Additionally, the Swiss National Bank increased its stake by 14.2%, now holding 2,480,755 shares valued at $16,966,000 after acquiring an additional 308,077 shares in the previous quarter.
Other notable adjustments include Bank of New York Mellon Corp, which boosted its holdings by 5.1%, now owning 1,709,301 shares worth $11,760,000, and Legal & General Group Plc, which expanded its position by 10.4%, resulting in ownership of 3,792,583 shares valued at $26,006,000. Arrowstreet Capital Limited Partnership significantly increased its stake by 34.4%, acquiring an additional 2,563,805 shares, bringing its total to 10,008,447 shares worth $68,693,000. Overall, hedge funds and institutional investors control approximately 13.38% of ICL Group’s stock.
About ICL Group
Founded through the consolidation of Israeli government-owned chemical operations, ICL Group is a global leader in specialty minerals and chemicals, with its headquarters located in Tel Aviv, Israel. The company traces its origins back to state-operated mineral extraction in the Negev and Dead Sea regions. Over the years, ICL has expanded its capabilities through strategic acquisitions and technological advancements, culminating in a public listing on the New York Stock Exchange (NYSE: ICL).
The company’s operations are divided into three primary business areas, focusing on delivering essential products to consumers and industries worldwide. As ICL Group navigates a complex market landscape, analysts will continue to monitor its performance and strategic initiatives in the coming quarters.
